Rosty Raykov - 05 Mar 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Rosty Raykov
Issuer symbol
FENC
Transactions as of
05 Mar 2025
Net transactions value
-$67,900
Form type
4
Filing time
06 Mar 2025, 17:32:16 UTC
Previous filing
28 Feb 2025
Next filing
01 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale $67,900 -10,000 -13% $6.79 68,725 05 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.